ISSN: 1885-5857 Impact factor 2023 7.2
Vol. 76. Num. 10.
Pages 828-831 (October 2023)

Scientific letter
STEMI code cancelation after telematic assessment: patient characteristics and prognosis

Pacientes con cancelación del código infarto tras valoración telemática: características y pronóstico

Carmen Martín DomínguezaJaime Aboal ViñasabPablo Loma-Osorio RincónaBlanca Herrera MartínezaVíctor Agudelo MontañezaRamón Brugada Terradellasab
Imagen extra
Rev Esp Cardiol. 2023;76:828-31
To the Editor,

The use of new technologies in ST-segment elevation myocardial infarction (STEMI) networks has been shown to shorten time to reperfusion by improving communication and coordination between physicians responsible for the diagnosis, transfer, and treatment of patients.1 Technologies such as mobile apps offer several advantages, including a reduction in the number of unnecessary transfers.1

The aim of this study was to compare clinical characteristics, electrocardiogram (ECG) patterns triggering infarction code activation, final diagnoses, clinical outcomes, and in-hospital mortality between 2 groups of patients: those who were transferred for emergent percutaneous coronary intervention (PCI) and those whose transfer was canceled. We prospectively analyzed all infarction codes activated in 2022. During these activations, the first medical contact, along with the on-call cardiologist and interventional cardiologist, shared clinical data and ECG results through the ODISEA2 mobile app. The study was approved by the ethics committee at our hospital; prior informed consent was obtained from all patients involved.

A total of 406 codes were activated through ODISEA during the study period; 284 transfers (70%) were completed (transfer group) and 122 (30%) were canceled (cancellation group). The decision to cancel a transfer was made jointly by the on-call cardiology team and the first medical contact.

The characteristics of the cancellation and transfer groups are summarized in table 1. Patients whose transfers were canceled were more likely to be women (38.5% vs 24%, P=.004) and to have a history of hypertension (70% vs 55%, P=.003), dyslipidemia (54.1% vs 39.1%, P=.005), and previous ischemic heart disease (21.3% vs 10.9%, P=.006).

Table 1.

Comparison of patients with suspected STEMI in the transfer group (transferred for PCI) and cancellation group (transfer canceled)

Baseline characteristic  All patients (n=406)  Patients with canceled transfers (n=122)  Patients who were transferred (n=284)  P 
Age, y  67 (13.9)  69 (15.9)  66 (12.8)  .05 
Women  116 (28.6)  47 (38.5)  69 (24.3)  .004 
Smokers  135 (33.3)  24 (19.7)  111 (39.1)  <.001 
Hypertension  242 (59.6)  86 (70.5)  156 (54.9)  .003 
Diabetes mellitus  115 (28.3)  37 (30.3)  78 (27.5)  .5 
Dyslipidemia  177 (43.6)  66 (54.1)  111 (39.1)  .005 
Previous stroke/TIA  21 (5.2)  11 (9)  10 (3.5)  .02 
Previous AMI  57 (14)  26 (21.3)  31 (10.9)  .006 
Previous PCI  47 (11.6)  18 (14.8)  29 (10.2)  .19 
Previous surgical revascularization  9 (2.2)  3 (2.5)  6 (2.1)  .82 
Survival after sudden cardiac arrest  16 (3.9)  5 (4.1)  11 (3.9)  .9 
First medical contact
Emergency medical services  141 (34.7)  51 (41.8)  90 (31.7)  .04 
Primary care  88 (21.7)  18 (14.8)  70 (24.6)   
Hospital without interventional cardiologist  177 (43.6)  53 (43.4)  124 (43.7)   
Diagnostic ECG pattern        <.001 
ST-segment elevation  279 (68.7)  26 (21.3)  253 (89.1)   
ST-segment depression  36 (8.8)  28 (23)  8 (2.8)   
LBBB  26 (6.4)  17 (13.9)  9 (3.2)   
RBBB  9 (2.2)  6 (4.9)  3 (1.1)   
Pacemaker rhythm  6 (1.5)  5 (4.1)  1 (0.4)   
Other  50 (12.4)  40 (32.8)  10 (3.4)   
Hospital admission  63 (15.5)  56 (46)  7 (2.4)  <.001 
PCI  323 (79.6)  41 (33.6)  282 (99.3)  <.001 
Final diagnosis of ACS  297 (73.2)  40 (32.8)  257 (90.5)  <.001 
Final diagnosis        <.001 
STEMI  240 (59.1)  3 (2.5)  237 (83.5)   
NSTEMI  51 (12.6)  33 (27)  18 (6.3)   
Unstable angina  6 (1.5)  4 (3.3)  2 (0.7)   
Other  109 (26.8)  82 (67.2)  27 (9.5)   
PCI findings        <.001 
Single-vessel disease  185 (57.3)  15 (36.6)  170 (60.3)   
Double-vessel disease  53 (16.4)  4 (9.8)  49 (17.4)   
Triple-vessel disease  45 (13.9)  9 (22)  36 (12.8)   
Coronary arteries without lesions  40 (12.4)  13 (31.7)  27 (9.6)   
Truncus arteriosus  15 (4.6)  15 (5.3)  .13 
Percutaneous revascularization  250 (77.4)  18 (43.9)  232 (82.3)  <.001 
In-hospital mortality  27 (6.7)  14 (11.4)  12 (4.2)  .003 

ACS, acute coronary syndrome; AMI, acute myocardial infarction; LBBB, left branch bundle block; NSTEMI, non–ST-elevation myocardial infarction; PCI, percutaneous coronary intervention; RBBB, right branch bundle block; STEMI, ST-elevation myocardial infarction; TIA, transient ischemic attack.

Values are expressed as mean±SD or No. (%).

The ECG patterns for patients in the cancellation group are shown in figure 1A. The most common patterns were ST-segment depression and intraventricular conduction disorders (complete left bundle branch block, complete right bundle branch block, and pacemaker rhythms).

Figure 1.

A, ECG patterns in patients whose transfer was canceled following infarction code activation. B, Final diagnoses in these patients. The pie chart on the right shows a breakdown of all diagnoses. The most common acute coronary syndrome diagnoses are shown in the pie chart on the left. ECG, electrocardiogram; STEMI, ST-segment elevation myocardial infarction; NSTEMI, non–ST-segment elevation myocardial infarction.

(0.31MB).

All patients in the cancellation group were transferred to a regional or tertiary care hospital. The choice of hospital was agreed on by the parties involved and determined by the perceived severity. Almost half of these patients (46%) were discharged directly from the emergency department. Of those admitted to hospital, one-third were scheduled for PCI. Coronary artery lesions were more common in this group than in the emergent PCI group (31.7% vs 9.6%, P=.001).

Most patients (90.5%) who underwent emergent PCI were diagnosed with acute coronary syndrome (ACS) (83.5% had STEMI, 6.3% non–ST-elevation myocardial infarction [NSTEMI], and 0.7% unstable angina). Just 32.8% of patients in the cancellation group had a final diagnosis of ACS (2.5% were diagnosed with STEMI, 27% with NSTEMI, and 3.3% with unstable angina). The final diagnoses of patients whose transfers were canceled are shown in figure 1B. The most common diagnoses were ACS (32.8%) and nonspecific chest pain (22.9%).

In-hospital mortality varied significantly between the groups, with a higher percentage of deaths occurring in the cancellation group (11.4% vs 4.2% in the transfer group, P=.001). Most deaths in patients with canceled transfers (79%) were due to nonischemic causes: sepsis (26.6%), aortic dissection (17.7%), pulmonary thromboembolism (17.7%), neurologic disorders (17.7%), and cancer (17.7%).

We have described the characteristics and clinical outcomes of patients with suspected STEMI whose transfer was canceled by the care team members based on information transmitted through the mobile ODISEA app.

The cancellation rate in our series was high (30%), which is consistent with previously reported rates.3,4 Pretransfer cancellation is common in clinical practice but requires the use of a communication platform that meets a series of requisites: the ability to share information quickly in compliance with data protection laws, a feature enabling the parties involved to agree on the cancellation (chat box), and the capability to record case information for subsequent follow-up. All these features are included in the ODISEA app, allowing us to integrate a STEMI communication platform into our infarction code program for the first time and enabling the characterization of patients with canceled transfers.

Rates of inappropriate cancellations (corresponding to patients with acute occlusion of the culprit artery) are seldom reported in clinical trials, despite the importance of this information. The cancellation rate in our series was 2.5% (3 patients, all with difficult-to-interpret ECG patterns). Although cancellation of activations deemed inappropriate is common practice, there is a risk that a small proportion of patients will have an actual STEMI. In a report on 886 cardiac catheterization laboratory cancellations, Lange et al.4 detected 9 inappropriate cancellations (1%), all in patients with an acute occlusion subsequently detected by PCI. Promising results have been reported for machine learning algorithms that can predict STEMI on ECG.5 This technology could help reduce human error.

The cancellation group was characterized by high comorbidity, perceived severity, difficult-to-interpret ECGs, and heterogeneous final diagnoses, ranging from nonserious conditions to conditions with high in-hospital mortality. The in-hospital mortality rate in our series was 11.4%. Similarly high short- and long-term rates have been described in other reports of canceled activations.3,4

The main limitations of this study are its small sample size and single-center design. More research is needed to confirm our findings and explore their generalizability to other health care regions.

In conclusion, patients with suspected STEMI whose transfers are canceled account for a significant proportion of infarction code activations. These patients have multiple comorbidities, unusual ECG patterns, and high in-hospital mortality. Although diagnosis is challenging, use of new technologies such as mobile apps could lead to improved management.

Funding

Training and research grant from Asociación de Cardiopatía Isquémica y Cuidados Críticos Cardiológicos (SECACIC-FOR-NAC 22/002). Grant from Sociedad Española de Cardiología, Spain.

Authors’ Contributions

Design: C. Martín Domínguez and J. Aboal Viñas. Field work: C. Martín Domínguez, B. Herrera Martínez, and V. Agudelo Montañez. Statistical analysis: J. Aboal Viñas. Manuscript draft and formatting: C. Martín Domínguez, J. Aboal Viñas, and P. Loma-Osorio Rincón. All authors contributed to drafting and revising the paper, and they all read and approved the final version.

Conflicts of Interest

None declared.

References
[1]
M. Studencan, D. Alusik, L. Plachy, et al.
Significant benefits of new communication technology for time delay management in STEMI patients.
PLoS One., (2018), 13 pp. e0205832
[2]
J. Aboal, R. Ramos, I. Boada, V. Agudelo, J. Palacios, V. Pérez.
Use of new technologies in the transfer of patients with STEMI. Results from the pilot test ODISEA APP.
REC Interv Cardiol., (2023), 5 pp. 66-68
[3]
A. Faour, R. Pahn, C. Cherrett, et al.
Late Outcomes of Patients with Prehospital ST-segment Elevation and Appropriate Cardiac Catheterization Laboratory Nonactivation.
J Am Heart Assoc., (2022), 11 pp. e025602
[4]
D.C. Lange, S. Conte, E. Pappas-Block, et al.
Cancellation of the Cardiac Catheterization Lab after Activation for ST-segment-Elevation Myocardial Infarction.
Circ Cardiovasc Qual Outcomes., (2018), 11 pp. e004464
[5]
K.W. Chen, Y.C. Wang, M.H. Liu, et al.
Artificial intelligence-assisted remote detection of ST-elevation myocardial infarction using a mini-12-lead electrocardiogram device in prehospital ambulance care.
Front Cardiovasc Med., (2022), 9 pp. 1001982
Are you a healthcare professional authorized to prescribe or dispense medications?